How to Invest in the Rise of Cannabis-Infused Beverages
November 18th, 2020
App, Exclusive, News, Top Story
The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry has evolved to provide a growing array of different products, including tinctures, topicals, edibles—and beverages.
Let’s take a look at the rise of cannabis-infused beverages and how you can invest in Innoviom, Inc.—a pioneer in the space—with as little as $2,500 through the MAZAKALI platform to capitalize on these trends.
Cannabis beverages are projected to become a $2.8 billion market by 2025, according to Grand View Research, which represents a blistering 17.8% compound annual growth rate. While the industry is highly fragmented at the moment, Molson Coors projects that cannabis drinks will eventually represent one-third of all cannabis sales as the industry matures.
Several large companies have already begun to position themselves in the space:
- Heineken launched Hi-Fi Hops—a CBD and THC-infused beverage with zero calories.
- Molson Coors took a controlling stake in HEXO Inc., a Canadian licensed producer.
- Anheuser-Busch InBev invested $50 million in a joint venture with Tilray Inc.
- Constellation Brands acquired a 38% stake in Canopy Growth Corp. for $4 billion.
Many alcohol conglomerates believe that THC-infused beverages could compete with alcohol in the future and seek to position themselves to diversify risk. However, Millennials appear to be equally interested in CBD-infused functional beverages that incorporate natural substances, like adaptogens, probiotics and vitamins, to improve wellness.
Innoviom Makes Big Progress
Innoviom was founded by executives from Coca-Cola, Pepsi, RedBull and other leading beverage brands to build on these CBD wellness trends and take them to scale. The company’s Wowie™ brand is a hemp-infused beverage that contains 20mg of hemp and a mix of adaptogens designed to promote relaxation.
In combination with Tranquini and its new NaturGeeks brands, the company has been consistently doubling its sales each month through Amazon.com and other online platforms. Management expects to be live in the UK on December 1 and rollout its products in the European Union in January of next year amid its international expansion.
With an established supply chain, manufacturing and distribution network already in place, the company is well on its way to expanding its presence throughout the United States. The company’s move to trademark the name in 120 countries and seek regulatory approval in 30+ countries suggests that further international expansion is also in the cards.
How to Invest in Innoviom
Innoviom has recently announced a $3 million capital raise in order to support its growth. While the company has already closed $1.2 million in funding for this round, interested investors still have an opportunity to participate in the remainder of the financing round over the coming weeks.
Accredited investors can participate in a direct private placement with a minimum investment of $30,000 or invest in MAZAKALI’s Special Investment Vehicle with a minimum investment of just $2,500. For more information, sign up for MAZAKALI’s platform and access the terms.
The Bottom Line
Cannabis beverages have already attracted tremendous interest in both the alcohol and wellness industries. With its unique combination of cannabinoid and non-cannabinoid relaxation beverages, Innoviom is well positioned to benefit from an increase in demand for CBD-infused functional beverages.
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.